Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

Arkema Earnings Release 2023

Nov 9, 2023

1117_iss_2023-11-09_dfa9814c-d48e-455c-83f0-8bfb911fda09.pdf

Earnings Release

Open in viewer

Opens in your device viewer

Colombes, 9 November 2023

ARKEMA: THIRD- THIRD-QUARTER 2023 RESULTS QUARTER RESULTS

Arkema achieved a solid EBITDA margin and high cash generation in an ongoing context of low volumes reflecting the current economic environment.

  • Sales of €2.3 billion, down by 17.2% at constant currency compared with Q3'22:
    • Volumes down by 6.6% year-on-year in an environment of generally slow demand comparable to that of previous quarters
    • 10.6% negative price effect reflecting lower raw materials, as well as price normalization in PVDF and upstream acrylics following the exceptional market conditions in 2022
  • EBITDA at €386 million, down compared with the prior year's high comparison base (€495 million in Q3'22), and EBITDA margin holding up well at 16.6% (16.7% in Q3'22), reflecting the strength of the Group's positioning and the initiatives taken to adapt to the economic climate
  • Adjusted net income of €177 million (€260 million in Q3'22), representing €2.38 per share
  • High cash generation with recurring cash flow of €312 million (€434 million in Q3'22) and net debt at €2,419 million including hybrid bonds (€2,645 million at end-June 2023), representing 1.7x last-twelvemonths EBITDA
  • As indicated last September at the Capital Markets Day, Arkema confirms its EBITDA forecast of around €1.5 billion in 2023, supported in particular by the resilience of several product lines and ongoing cost-saving actions

Following Arkema's Board of Directors' meeting held on 8 November 2023 to review the Group's consolidated financial information for the third quarter of 2023, Chairman and CEO Thierry Le Hénaff said:

"In line with the first half of the year, demand continued to be weak this quarter. Arkema's performance nevertheless remained solid, supported by the quality of its portfolio of technologies serving sustainable megatrends and by the strengthening of cost initiatives. In an uncertain context marked by heightened geopolitical tensions, we continue to strictly manage our operations and to adapt thanks to the agility and commitment of our teams.

Moreover, Arkema is fully mobilized to prepare for the future. At the Capital Markets Day held in Paris on 27 September, we detailed our longer-term strategy and set ambitious financial targets for 2028. Arkema will focus its investments on high-growth areas, centered on innovative, high performance materials for a more sustainable world. Thanks to the technologies it has acquired or developed in recent years, and the expertise it has built up in markets with superior growth potential such as batteries, advanced electronics and sustainable consumer goods, the Group is now ready to embark on this new stage in its development, mainly focused on organic growth. Several important projects, which started up this year or which will shortly be completed, will contribute to the Group's growth in 2024.

As a key component of our strategy, we will also pursue our climate actions, and in particular the reduction of our CO2 emissions, bolstered by the SBTi's validation of our 1.5°C trajectory by 2030, and in order to pave the way for Net-Zero by 2050."

KEY FIGURES

in millions of euros Q3'23 Q3'22 Change
Sales 2,326 2,972 -21.7%
EBITDA 386 495 -22.0%
Specialty Materials 346 458 -24.5%
Intermediates 55 59 -6.8%
Corporate -15 -22
EBITDA margin 16.6% 16.7%
Specialty Materials 16.4% 16.9%
Intermediates 26.7% 24.0%
Recurring operating income (REBIT) 246 356 -30.9%
REBIT margin 10.6% 12.0%
Adjusted net income 177 260 -31.9%
Adjusted net income per share (in €) 2.38 3.52 -32.4%
Recurring cash flow 312 434
Free cash flow 273 397
Net debt including hybrid bonds 2,419 2,615
€2,366m as of 31/12/2022

THIRD-QUARTER 2023 BUSINESS PERFORMANCE

At €2,326 million, Group sales were down by 21.7% relative to the particularly elevated level of third-quarter 2022. Volumes declined by 6.6%, impacted as in recent quarters by continued weak demand in Europe and North America in most end markets, which overshadowed the good performance of certain sectors such as automotive and energy. In Asia, volumes rose slightly in a market struggling to gain impetus, supported in particular by the positive momentum in batteries. The 10.6% negative price effect reflects the expected normalization of market conditions in PVDF and upstream acrylics, as well as lower raw materials prices. The scope effect was neutral on sales, with small acquisitions in Adhesive Solutions and Coating Solutions offset by the divestment of Febex. The currency effect was more pronounced at negative 4.5%, primarily reflecting the strength of the euro against the US dollar and the Chinese yuan.

EBITDA came to €386 million (€495 million in Q3'22), reflecting contrasting trends between product lines and regions. Adhesive Solutions and Performance Additives were up year-on-year. The decline of EBITDA in High Performance Polymers was mainly linked to the high comparison base of the prior year, which benefited from exceptional profits in PVDF, and the decline in Coating Solutions to less favorable market conditions in upstream acrylics. In addition, strict price management in a context of easing tightness in raw materials, as well as cost-cutting initiatives implemented within the Group, mitigated the impact of the general decline in volumes linked to the macroeconomic environment. Despite this much less buoyant context than in 2022, the EBITDA margin remained solid and comparable to the prior-year's at 16.6% (16.7% in Q3'22).

The recurring operating income (REBIT) of €246 million (€356 million in Q3'22) included €140 million in recurring depreciation and amortization, stable compared with Q3'22. REBIT margin thus amounted to 10.6% (12.0% in Q3'22).

Adjusted net income came to €177 million (€260 million in Q3'22), representing €2.38 per share. Excluding exceptional items, the tax rate amounted to approximately 21% of recurring operating income in the first nine months of the year.

CASH FLOW AND NET DEBT AT 30 SEPTEMBER 2023

The Group generated high recurring cash flow of €312 million in third-quarter 2023 (€434 million in Q3'22). This figure includes a cash inflow of €138 million from the change in working capital, which reflects the reduced level of business activity and lower raw materials costs. At end-September 2023, working capital represented 16.3% of annualized sales (15.5% at end-September 2022). Recurring cash flow also included recurring capital expenditure of €137 million (€131 million in Q3'22).

Free cash flow amounted to €273 million (€397 million in Q3'22) and included exceptional capital expenditure of €5 million (€21 million in Q3'22).

Net debt including hybrid bonds came to €2,419 million (€2,645 million at end-June 2023), and the net debt to last-twelve-months EBITDA ratio stood at 1.7x.

THIRD-QUARTER 2023 PERFORMANCE BY SEGMENT

ADHESIVE SOLUTIONS (29% OF TOTAL GROUP SALES)

Change Q3'22 Q3'23 in millions of euros
-9.9% 757 682 Sales
+8.9% 90 98 EBITDA
11.9% 14.4% EBITDA margin
+11.6% 69 77 Recurring operating income (REBIT)
9.1% 11.3% REBIT margin

Sales in the Adhesive Solutions segment amounted to €682 million, down by 9.9% year-on-year, impacted mainly by a 5.2% negative currency effect. Volumes decreased by 3.4% compared with the prior year's baseline, which had already been impacted in Europe by the start of destocking. Demand remained weak in most end markets, particularly in Europe and the United States. Volumes were up in Asia, supported by slightly more dynamic activity overall. The price effect in the segment was a negative 1.8% in a context of lower raw materials prices, while the scope effect, corresponding to the integration of Polytec PT, was limited at a positive 0.5%.

At €98 million, EBITDA was up by 8.9% compared with third-quarter 2022, benefiting from strict price management, operational excellence and cost control initiatives, as well as an improved product mix toward high value-added solutions. In this ongoing context of low volumes, the EBITDA margin improved by 250 bps to 14.4% (11.9% in Q3'22), reaching a level more aligned with the targeted medium-term progression.

ADVANCED MATERIALS (37% OF TOTAL GROUP SALES)

Change Q3'22 Q3'23 in millions of euros
-24.3% 1,131 856 Sales
-27.4% 237 172 EBITDA
21.0% 20.1% EBITDA margin
-40.1% 167 100 Recurring operating income (REBIT)
14.8% 11.7% REBIT margin

Sales in the Advanced Materials segment totaled €856 million, down by 24.3% compared with third-quarter 2022. Performance was impacted by a price effect of negative 13.9%, mainly reflecting the normalization of PVDF in batteries in China. Volumes were down by 5.3% overall, declining in Performance Additives, where they were impacted in particular by subdued demand in Europe, but rising in High Performance Polymers, driven by the automotive and energy markets, as well as by new developments in areas linked to sustainable megatrends such as sustainable lifestyle, electric mobility and water filtration. The scope effect was a negative 1.0%, linked to the divestment of Febex, and the currency effect was a negative 4.1%.

Segment EBITDA came to €172 million, a significant decrease compared with third-quarter 2022 (€237 million in Q3'22), which had benefited from a temporary period of highly favorable market conditions in PVDF. Performance Additives' EBITDA rose significantly despite the decrease in volumes, thus confirming the quality of the portfolio and the positive momentum in niche applications driven by sustainable megatrends, particularly renewable energies. In this context, the EBITDA margin held up well at 20.1% (21.0% in Q3'22).

COATING SOLUTIONS (25% OF TOTAL GROUP SALES)

Change Q3'22 Q3'23 in millions of euros
-30.7% 825 572 Sales
-42.0% 131 76 EBITDA
15.9% 13.3% EBITDA margin
-56.6% 99 43 Recurring operating income (REBIT)
12.0% 7.5% REBIT margin

Sales in the Coating Solutions segment totaled €572 million, down by a sharp 30.7% year-on-year (€825 million in Q3'22), including an 18.4% negative price effect related in particular to less favorable market conditions in upstream acrylics and to lower raw materials prices. Segment volumes rose in Asia, but fell by 9.5% overall, impacted by weak demand. The scope effect was a positive 0.7%, reflecting the integration of Polimeros Especiales, and the currency effect was a negative 3.5%.

At €76 million, the segment's EBITDA was lower than in the prior year (€131 million in Q3'22), impacted mainly by less favorable market conditions in acrylic monomers. EBITDA for downstream product lines held up better despite the decline in volumes, supported by an improved product mix toward higher value-added solutions and dynamic price management in a context of lower raw materials prices. In this significantly more challenging environment, the decline in the EBITDA margin was limited thanks to initiatives undertaken by the segment's teams and the integration of the acrylics value chain, reaching 13.3% (15.9% in Q3'22).

INTERMEDIATES (9% OF TOTAL GROUP SALES)

Change Q3'22 Q3'23 in millions of euros
-16.3% 246 206 Sales
-6.8% 59 55 EBITDA
24.0% 26.7% EBITDA margin
-4.5% 44 42 Recurring operating income (REBIT)
17.9% 20.4% REBIT margin

Sales in the Intermediates segment declined by 16.3% year-on-year to €206 million (€246 million in Q3'22). The 12.6% fall in volumes was mainly due to weak demand for acrylics in Asia. The price effect was a slightly positive 3.7%, reflecting solid momentum in refrigerant gases in the United States and Europe. The currency effect was a negative 7.4%, with the segment impacted by a stronger euro against the Chinese yuan.

EBITDA held up well at €55 million, down by 6.8% year-on-year, and the EBITDA margin remained at a very good level at 26.7% (24.0% in Q3'22).

THIRD-QUARTER 2023 HIGHLIGHTS

At the Capital Markets Day on 27 September 2023, Arkema presented the new stage of its development and unveiled its 2028 ambition. Building on its achievements since the April 2020 strategy update, the Group now aims to accelerate its organic sales growth in the medium term, by capitalizing on its recent or future industrial investments in high value-added technological solutions serving fast-growing market segments supported by sustainable megatrends.

By 2028, Arkema thus aims to achieve sales of around €12 billion with an elevated EBITDA margin of around 18%.

The Group will also capitalize on the recent validation by SBTi of its 1.5°C trajectory by 2030 to further strengthen its decarbonization initiatives, paving the way for Net-Zero by 2050.

On 27 September 2023, the Group also unveiled three industrial projects aligned with its new 2028 ambition:

  • the implementation by 2026 of a new, patented purification technology at its acrylics production site in Carling (France), which will enable the Group to decarbonize production by reducing CO2 emissions by 20%, and to improve the site's operational efficiency and environmental footprint toward the highest standards, while optimizing competitiveness;
  • the increase, at its Beaumont site in the United States, of its global production capacity of DMDS (dimethyl disulfide), an additive that is key in the production of renewable fuels, in a fast-growing biofuels market, driven by the demand for decarbonization of road and air transport; and
  • a two-and-a-half-fold increase of its organic peroxide production capacity at its Changshu site in China, to support its Asian customers in fast-growing markets, notably in renewable energies.

OUTLOOK FOR 2023

The economic environment remains challenging as the year draws to a close, in line with the level seen since the beginning of the year, and is marked by low volumes in most end markets and uncertainties in all three regions, as well as by heightened geopolitical tensions.

In this context, the Group will continue to work on the elements under its control, in particular managing costs, optimizing working capital and rolling out ongoing technological developments with its customers and partners. Beyond that, Arkema will ensure the successful completion of several key projects that will contribute to the growth in 2024, including the ramp-up of the bio-based plant in Singapore, HF supply in the United States, the development of Sartomer® photocure resins in China, and the finalization in the United States of the HFO-1233zd project for batteries and building insulation.

Based on the results of the first nine months and the momentum expected in the fourth quarter, and as indicated last September at the Capital Markets Day, Arkema confirms its EBITDA forecast of around €1.5 billion in 2023, supported in particular by the resilience of several product lines and ongoing cost-saving initiatives. The Group is also aiming for a high EBITDA to cash conversion of around 40%.

Further details concerning the Group's third-quarter 2023 results are provided in the "Third-quarter 2023 results and highlights" presentation and the "Factsheet", both available on Arkema's website at: www.arkema.com/global/en/investor-relations/

FINANCIAL CALENDAR

29 February 2024: Publication of full-year 2023 results

7 May 2024: Publication of first-quarter 2024 results

15 May 2024: Annual general meeting

DISCLAIMER

The information disclosed in this press release may contain forward-looking statements with respect to the financial position, results of operations, business and strategy of Arkema. In a context of significant geopolitical tensions, where the outlook for the global economy remains uncertain, the retained assumptions and forward-looking statements could ultimately prove inaccurate.

Such statements are based on management's current views and assumptions that could ultimately prove inaccurate and are subject to risk factors such as (but not limited to) changes in raw materials prices, currency fluctuations, the pace at which cost-reduction projects are implemented, rising geopolitical tensions, and changes in general economic and financial conditions. Arkema does not assume any liability to update such forward-looking statements whether as a result of any new information or any unexpected event or otherwise. Further information on factors which could affect Arkema's financial results is provided in the documents filed with the French Autorité des marchés financiers.

Balance sheet, income statement and cash flow statement data, as well as data relating to the statement of changes in shareholders' equity and information by segment included in this press release are extracted from the consolidated financial information at 30 September 2023 as reviewed by Arkema's Board of Directors on 8 November 2023. Quarterly financial information is not audited.

Information by segment is presented in accordance with Arkema's internal reporting system used by management.

Details of the main alternative performance indicators used by the Group are provided in the tables appended to this press release. For the purpose of analyzing its results and defining its targets, the Group also uses EBITDA margin, which corresponds to EBITDA expressed as a percentage of sales, EBITDA equaling recurring operating income (REBIT) plus recurring depreciation and amortization of tangible and intangible assets, as well as REBIT margin, which corresponds to recurring operating income (REBIT) expressed as a percentage of sales.

For the purpose of tracking changes in its results, and particularly its sales figures, the Group analyzes the following effects (unaudited analyses):

  • scope effect: the impact of changes in the Group's scope of consolidation, which arise from acquisitions and divestments of entire businesses or as a result of the first-time consolidation or deconsolidation of entities. Increases or reductions in capacity are not included in the scope effect;
  • currency effect: the mechanical impact of consolidating accounts denominated in currencies other than the euro at different exchange rates from one period to another. The currency effect is calculated by applying the foreign exchange rates of the prior period to the figures for the period under review;
  • price effect: the impact of changes in average selling prices is estimated by comparing the weighted average net unit selling price of a range of related products in the period under review with their weighted average net unit selling price in the prior period, multiplied, in both cases, by the volumes sold in the period under review;
  • volume effect: the impact of changes in volumes is estimated by comparing the quantities delivered in the period under review with the quantities delivered in the prior period, multiplied, in both cases, by the weighted average net unit selling price in the prior period.

Building on its unique set of expertise in materials science, Arkema offers a portfolio of first-class technologies to address ever-growing demand for new and sustainable materials. With the ambition to become in 2024 a pure player in Specialty Materials, the Group is structured into 3 complementary, resilient and highly innovative segments dedicated to Specialty Materials -Adhesive Solutions, Advanced Materials, and Coating Solutions- accounting for some 91% of Group sales in 2022, and a well-positioned and competitive Intermediates segment. Arkema offers cutting-edge technological solutions to meet the challenges of, among other things, new energies, access to water, recycling, urbanization and mobility, and fosters a permanent dialogue with all its stakeholders. The Group reported sales of around €11.5 billion in 2022, and operates in some 55 countries with 21,100 employees worldwide.

Investor relations contacts

Béatrice Zilm
Peter Farren
Mathieu Briatta
Caroline Chung

Media contacts

+33 (U)I 49 00 1 5 నర
+33 (0)1 49 00 73 12
+33 (0)1 49 00 72 07
+33 (0)1 49 00 74 37

Béatrice Zilm +33 (0)1 49 00 75 58 [email protected] Peter Farren +33 (0)1 49 00 73 12 [email protected] Mathieu Briatta +33 (0)1 49 00 72 07 [email protected] Caroline Chung +33 (0)1 49 00 74 37 [email protected]

Gilles Galinier +33 (0)1 49 00 70 07 [email protected] Anne Plaisance +33 (0)6 81 87 48 77 [email protected]

A French société anonyme (limited company) with share capital of €750,435,140 Registered in Nanterre: RCS 445 074 685 Nanterre

a

ARKEMA financial statements

3

Consolidated financial information at the end of September 2023

Consolidated financial statements as end of December 2022 have been audited.

CONSOLIDATED INCOME STATEMENT

rd quarter 2023
3
rd quarter 2022
3
(In millions of euros)
Sales 2,326 2,972
Operating expenses (1,835) (2,356)
Research and development expenses (68) (66)
Selling and administrative expenses (209) (214)
Other income and expenses (32) (15)
Operating income 182 321
Equity in income of affiliates (2) (3)
Financial result (9) (17)
Income taxes (54) (76)
Net income 117 225
Attributable to non-controlling interests 3 1
Net income - Group share 114 224
Earnings per share (amount in euros) 1.39 2.88
Diluted earnings per share (amount in euros) 1.37 2.86
End of September 2023 End of September 2022
(In millions of euros)
Sales 7,292 9,043
Operating expenses (5,757) (6,841)
Research and development expenses (204) (199)
Selling and administrative expenses (661) (649)
Other income and expenses (71) (85)
Operating income 599 1,269
Equity in income of affiliates (7) (4)
Financial result (44) (31)
Income taxes (146) (277)
Net income 402 957
Attributable to non-controlling interests 4 3
Net income - Group share 398 954
Earnings per share (amount in euros) 5.12 12.68
Diluted earnings per share (amount in euros) 5.09 12.62

CONSOLIDATED STATEMENT OF COMPREHENSIVE INCOME

rd quarter 2023
3
rd quarter 2022
3
(In millions of euros)
Net income 117 225
Hedging adjustments (13) 3
Other items 0
Deferred taxes on hedging adjustments and other items 0 0
Change in translation adjustments 109 240
Other recyclable comprehensive income 96 243
Impact of remeasuring unconsolidated investments 0
Actuarial gains and losses 26 52
Deferred taxes on actuarial gains and losses (5) (10)
Other non-recyclable comprehensive income 21 42
Total income and expenses recognized directly in equity 117 285
Total comprehensive income 234 510
Attributable to non-controlling interest 3 2
Total comprehensive income - Group share 231 508
End of September 2023 End of September 2022
(In millions of euros)
Net income 402 957
Hedging adjustments (51) 19
Other items 0
Deferred taxes on hedging adjustments and other items 2 (3)
Change in translation adjustments (34) 567
Other recyclable comprehensive income (83) 583
Impact of remeasuring unconsolidated investments 0 (1)
Actuarial gains and losses 19 167
Deferred taxes on actuarial gains and losses (4) (29)
Other non-recyclable comprehensive income 15 137
Total income and expenses recognized directly in equity (68) 720
Total comprehensive income 334 1,677
Attributable to non-controlling interest 2 5
Total comprehensive income - Group share 332 1,672

INFORMATION BY SEGMENT

rd quarter 2023
3
(In millions of euros) Adhesive
Solutions
Advanced
Materials
Coating
Solutions
Intermediates Corporate Total
Sales 682 856 572 206 10 2,326
EBITDA 98 172 76 55 (15) 386
Recurring depreciation and amortization of property, plant and
equipment and intangible assets
(21) (72) (33) (13) (1) (140)
Recurring operating income (REBIT) 77 100 43 42 (16) 246
Depreciation and amortization related to the revaluation of property,
plant and equipment and intangible assets as part of the allocation of the
purchase price of businesses
(26) (5) (1) (32)
Other income and expenses (10) (21) 0 (1) 0 (32)
Operating income 41 74 42 41 (16) 182
Equity in income of affiliates (2) (2)
Intangible assets and property, plant, and equipment additions 15 93 23 7 4 142
Of which: recurring capital expenditure 15 88 23 7 4 137
rd quarter 2022
3
(In millions of euros) Adhesive
Solutions
Advanced
Materials
Coating
Solutions
Intermediates Corporate Total
Sales 757 1,131 825 246 13 2,972
EBITDA 90 237 131 59 (22) 495
Recurring depreciation and amortization of property, plant and
equipment and intangible assets
(21) (70) (32) (15) (1) (139)
Recurring operating income (REBIT) 69 167 99 44 (23) 356
Depreciation and amortization related to the revaluation of property,
plant and equipment and intangible assets as part of the allocation of the
purchase price of businesses
(14) (5) (1) (20)
Other income and expenses (13) (9) 1 25 (19) (15)
Operating income 42 153 99 69 (42) 321
Equity in income of affiliates (3) 0 (3)
Intangible assets and property, plant, and equipment additions 21 94 29 4 4 152
Of which: recurring capital expenditure 21 73 29 4 4 131

INFORMATION BY SEGMENT

End of September 2023
(In millions of euros) Adhesive
Solutions
Advanced
Materials
Coating
Solutions
Intermediates Corporate Total
Sales 2,072 2,705 1,850 636 29 7,292
EBITDA 286 517 258 173 (64) 1,170
Recurring depreciation and amortization of property, plant and equipment
and intangible assets
(62) (207) (94) (38) (4) (405)
Recurring operating income (REBIT) 224 310 164 135 (68) 765
Depreciation and amortization related to the revaluation of property, plant
and equipment and intangible assets as part of the allocation of the
purchase price of businesses
(77) (13) (5) (95)
Other income and expenses (22) (37) (1) (1) (10) (71)
Operating income 125 260 158 134 (78) 599
Equity in income of affiliates (7) (7)
Intangible assets and property, plant, and equipment additions 48 230 62 15 11 366
Of which: recurring capital expenditure 48 213 62 15 11 349
End of September 2022
(In millions of euros) Adhesive
Solutions
Advanced
Materials
Coating
Solutions
Intermediates Corporate Total
Sales 2,206 3,319 2,647 839 32 9,043
EBITDA 291 793 530 282 (77) 1,819
Recurring depreciation and amortization of property, plant and equipment
and intangible assets
(57) (204) (95) (45) (4) (405)
Recurring operating income (REBIT) 234 589 435 237 (81) 1,414
Depreciation and amortization related to the revaluation of property, plant
and equipment and intangible assets as part of the allocation of the
purchase price of businesses
(42) (14) (4) (60)
Other income and expenses (45) (31) 1 23 (33) (85)
Operating income 147 544 432 260 (114) 1,269
Equity in income of affiliates (4) 0 (4)
Intangible assets and property, plant, and equipment additions 48 254 68 9 10 389
Of which: recurring capital expenditure 48 167 68 9 10 302

CONSOLIDATED CASH FLOW STATEMENT

End of September 2023 End of September 2022
(In millions of euros)
Operating cash flows
Net income 402 957
Depreciation, amortization and impairment of assets 512 492
Other provisions and deferred taxes (70) (36)
(Gains)/losses on sales of long-term assets (29) (31)
Undistributed affiliate equity earnings 7 4
Change in working capital (27) (384)
Other changes 15 37
Cash flow from operating activities 810 1,039
Investing cash flows
Intangible assets and property, plant, and equipment additions (366) (389)
Change in fixed asset payables (131) (99)
Acquisitions of operations, net of cash acquired (66) (1,614)
Increase in long-term loans (45) (49)
Total expenditures (608) (2,151)
Proceeds from sale of intangible assets and property, plant, and equipment 8 6
Proceeds from sale of operations, net of cash transferred 32 20
Repayment of long-term loans 56 43
Total divestitures 96 69
Cash flow from investing activities (512) (2,082)
Financing cash flows
Issuance (repayment) of shares and paid-in surplus 0
Purchase of treasury shares (32) (11)
Dividends paid to parent company shareholders (253) (222)
Interest paid to bearers of subordinated perpetual notes (16) (16)
Dividends paid to non-controlling interests and buyout of minority interests
Increase in long-term debt
(3)
397
(2)
5
Decrease in long-term debt (63) (62)
Increase / (Decrease) in short-term debt (31) 384
Cash flow from financing activities (1) 76
Net increase/(decrease) in cash and cash equivalents 297 (967)
Effect of exchange rates and changes in scope 11 (38)
Cash and cash equivalents at beginning of period 1,592 2,285
Cash and cash equivalents at end or the period 1,900 1,280

CONSOLIDATED BALANCE SHEET

30 September 2023 31 December 2022
(In millions of euros)
ASSETS
Goodwill 2,709 2,655
Intangible assets, net 2,099 2,178
Property, plant and equipment, net 3,434 3,429
Equity affiliates: investments and loans 16 24
Other investments 52 52
Deferred tax assets 165 166
Other non-current assets 235 245
TOTAL NON-CURRENT ASSETS 8,710 8,749
Inventories 1,347 1,399
Accounts receivable 1,396 1,360
Other receivables and prepaid expenses 198 202
Income tax receivables 103 130
Other current financial assets 13 57
Cash and cash equivalents 1,900 1,592
Assets held for sale 22
TOTAL CURRENT ASSETS 4,957 4,762
TOTAL ASSETS 13,667 13,511
LIABILITIES AND SHAREHOLDERS' EQUITY
Share capital 750 750
Paid-in surplus and retained earnings 6,332 6,218
Treasury shares (52) (20)
Translation adjustments 320 352
SHAREHOLDERS' EQUITY - GROUP SHARE 7,350 7,300
Non-controlling interests 41 39
TOTAL SHAREHOLDERS' EQUITY 7,391 7,339
Deferred tax liabilities 345 362
Provisions for pensions and other employee benefits 357 382
Other provisions and non-current liabilities 415 458
Non-current debt 2,955 2,560
TOTAL NON-CURRENT LIABILITIES 4,072 3,762
Accounts payable 946 1,149
Other creditors and accrued liabilities 464 437
Income tax payables 89 109
Other current financial liabilities 41 13
Current debt 664 698
Liabilities related to assets held for sale 4
TOTAL CURRENT LIABILITIES 2,204 2,410
TOTAL LIABILITIES AND SHAREHOLDERS' EQUITY 13,667 13,511

CONSOLIDATED STATEMENT OF CHANGES IN SHAREHOLDERS' EQUITY

Shares issued Treasury shares Shareholders'
(In millions of euros) Number Amount Paid-in
surplus
Hybrid
bonds
Retained
earnings
Translation
adjustments
Number Amount equity - Group
share
Non-controlling
interests
Shareholder
s' equity
At 1 January 2023 75,043,514 750 1,067 700 4,451 352 (231,087) (20) 7,300 39 7,339
Cash dividend - - - - (269) - - - (269) (2) (271)
Issuance of share capital - - - - - - - - - - -
Capital decrease by cancellation of treasury shares - - - - - - - - - - -
Purchase of treasury shares - - - - - - (357,726) (32) (32) - (32)
Cancellation of purchased treasury shares - - - - - - - - - - -
Grants of treasury shares to employees - - - - 0 - 1,235 0 0 - 0
Sale of treasury shares - - - - - - - - - - -
Share-based payments - - - - 19 - - - 19 - 19
Issuance of hybrid bonds - - - - - - - - - - -
Redemption of hybrid bonds - - - - - - - - - - -
Other - - - - 0 - - - - 2 2
Transactions with shareholders - - - - (250) - (356,491) (32) (282) (282)
Net income - - - - 398 - - - 398 4 402
Total income and expense recognized directly through
equity
- - - - (34) (32) - - (66) (2) (68)
Comprehensive income - - - - 364 (32) - - 332 2 334
At 30 September 2023 75,043,514 750 1,067 700 4,565 320 (587,578) (52) 7,350 41 7,391

ALTERNATIVE PERFORMANCE INDICATORS

To monitor and analyse the financial performance of the Group and its activities, the Group management uses alternative performance indicators. These are financial indicators that are not defined by the IFRS. This note presents a reconciliation of these indicators and the aggregates from the consolidated financial statements under IFRS.

RECURRING OPERATING INCOME (REBIT) AND EBITDA

(In millions of euros) End of September 2023 End of September 2022 rd quarter 2023
3
rd quarter 2022
3
OPERATING INCOME 599 1,269 182 321
- Depreciation and amortization related to the revaluation of tangible and intangible assets as part of the
allocation of the purchase price of businesses
(95) (60) (32) (20)
- Other income and expenses (71) (85) (32) (15)
RECURRING OPERATING INCOME (REBIT) 765 1,414 246 356
- Recurring depreciation and amortization of tangible and intangible assets (405) (405) (140) (139)
EBITDA 1,170 1,819 386 495

Details of depreciation and amortization of tangible and intangible assets:

(In millions of euros) End of September 2023 End of September 2022 rd quarter 2023
3
rd quarter 2022
3
Depreciation and amortization of tangible and intangible assets (512) (492) (178) (166)
Of which: Recurring depreciation and amortization of tangible and intangible assets (405) (405) (140) (139)
Of which: Depreciation and amortization related to the revaluation of assets as part of the allocation of the
purchase price of businesses
(95) (60) (32) (20)
Of which: Impairment included in other income and expenses (12) (27) (6) (7)

ADJUSTED NET INCOME AND ADJUSTED EARNINGS PER SHARE

(In millions of euros) End of September 2023 End of September 2022 rd quarter 2023
3
rd quarter 2022
3
NET INCOME - GROUP SHARE 398 954 114 224
- Depreciation and amortization related to the revaluation of tangible and intangible assets as part of the
allocation of the purchase price of businesses
(95) (60) (32) (20)
- Other income and expenses (71) (85) (32) (15)
- Other income and expenses - Non-controlling interests
- Taxes on depreciation and amortization related to the revaluation of assets as part of the allocation of the
purchase price of businesses 23 12 10 4
- Taxes on other income and expenses 14 5 6 (2)
- One-time tax effects (19) 3 (15) (3)
ADJUSTED NET INCOME 546 1,079 177 260
Weighted average number of ordinary shares 74,636,305 73,947,397
Weighted average number of potential ordinary shares 75,043,514 74,333,266
ADJUSTED EARNINGS PER SHARE (in euros) 7.32 14.59 2.38 3.52
DILUTED ADJUSTED EARNINGS PER SHARE (in euros) 7.28 14.52 2.36 3.50

RECURRING CAPITAL EXPENDITURE

(In millions of euros) End of September 2023 End of September 2022 rd quarter 2023
3
rd quarter 2022
3
INTANGIBLE ASSETS AND PROPERTY, PLANT, AND EQUIPMENT ADDITIONS 366 389 142 152
- Exceptional capital expenditure 17 87 5 21
- Investments relating to portfolio management operations
- Capital expenditure with no impact on net debt 0 0 0
RECURRING CAPITAL EXPENDITURE 349 302 137 131

CASH FLOWS

(In millions of euros) End of September 2023 End of September 2022 rd quarter 2023
3
rd quarter 2022
3
Cash flow from operating activities 810 1,039 393 508
+ Cash flow from investing activities (512) (2,082) (125) (232)
NET CASH FLOW 298 (1,043) 268 276
- Net cash flow from portfolio management operations (44) (1,628) (5) (121)
FREE CASH FLOW 342 585 273 397
Exceptional capital expenditure (17) (87) (5) (21)
- Non-recurring cash flow (77) (23) (34) (16)
RECURRING CASH FLOW 436 695 312 434

The net cash flow from portfolio management operations corresponds to the impact of acquisition and divestment operations.

Non-recurring cash flow corresponds to cash flow from other income and expenses.

NET DEBT

(In millions of euros) End of September 2023 End of December 2022
Non-current debt 2,955 2,560
+ Current debt 664 698
- Cash and cash equivalents 1,900 1,592
NET DEBT 1,719 1,666
+ Hybrid bonds 700 700
NET DEBT AND HYBRID BONDS 2,419 2,366

WORKING CAPITAL

(In millions of euros) End of September 2023 End of December 2022
Inventories
+ Accounts receivable 1,347
1,396
1,399
1,360
+ Other receivables including income taxes 301 332
+ Other current financial assets 13 57
- Accounts payable 946 1,149
- Other liabilities including income taxes 553 546
- Other current financial liabilities 41 13
WORKING CAPITAL 1,517 1,440

CAPITAL EMPLOYED

(In millions of euros) End of September 2023 End of December 2022
Goodwill, net 2,709 2,655
+ Intangible assets (excluding goodwill), and property, plant and equipment, net 5,533 5,607
+ Investments in equity affiliates 16 24
+ Other investments and other non-current assets 287 297
+ Working capital 1,517 1,440
CAPITAL EMPLOYED 10,062 10,023